HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Granulomatous hepatitis and fever of unknown origin. An 11-year experience of 23 cases with three years' follow-up.

Abstract
Granulomatous hepatitis is a common cause of fever of unknown origin in up to 13% of patients with prolonged fever. Attempts to define an exact etiology of the granulomatous hepatitis frequently does not yield a precise diagnosis, so that the physician must consider empiric treatment. In this paper we retrospectively review 23 patients in whom granulomatous hepatitis was found as part of the initial assessment of fever of unknown origin, and we report on their outcomes after an overall prospective follow-up of 37 months. In 26% a precise diagnosis was established at the time of assessment: Q-fever in three, mycobacterial disease in two, and histoplasmosis in one. In the remaining 74% no etiology was established after 44 months follow-up. Forty-one percent of the idiopathic group resolved spontaneously without therapy, and 18% received short-term prednisone or indomethacin with a favourable outcome. The remaining 41% required long-term prednisone therapy for a mean of 33.1 months, but all have remained afebrile and otherwise healthy after 59.6 months follow-up. We conclude that patients with fever of unknown origin who are diagnosed as having idiopathic granulomatous hepatitis have an excellent prognosis, even the minority who require long-term corticosteroids.
AuthorsD E Zoutman, E D Ralph, J V Frei
JournalJournal of clinical gastroenterology (J Clin Gastroenterol) Vol. 13 Issue 1 Pg. 69-75 (Feb 1991) ISSN: 0192-0790 [Print] United States
PMID2007749 (Publication Type: Journal Article)
Chemical References
  • Prednisone
Topics
  • Adult
  • Aged
  • Biopsy
  • Female
  • Fever of Unknown Origin (etiology)
  • Follow-Up Studies
  • Granuloma (complications, drug therapy, etiology, pathology)
  • Hepatitis (complications, drug therapy, etiology, pathology)
  • Humans
  • Male
  • Middle Aged
  • Prednisone (therapeutic use)
  • Prognosis
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: